Delayed progression of bull’s eye maculopathy

Chloroquine-induced maculopathy may progress years after drug cessation and an apparent period of visual stability. Both doctor and patients should be fully aware of the risks of retinal toxicity, including delayed onset and progression. It is therefore crucial that regular monitoring continues in a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BMJ case reports 2017-06, Vol.2017, p.bcr-2017-220598
Hauptverfasser:	Jain, Sunila, Jain, Neel Gautam
Format:	Artikel
Sprache:	eng
Schlagworte:	Aftercare Aged Antirheumatic Agents - adverse effects Antirheumatic Agents - toxicity Chloroquine - adverse effects Chloroquine - toxicity Disease Progression Drug dosages Electroretinography - methods Family medical history Female Fluorescein Angiography - methods Humans Learning from Errors Macular Degeneration - chemically induced Macular Degeneration - diagnostic imaging Outcome Assessment (Health Care) Patients Retinal Diseases - chemically induced Retinal Diseases - diagnosis Rheumatoid arthritis Tomography, Optical Coherence - methods United Kingdom Vision Disorders - diagnosis Vision Disorders - etiology Visual Acuity - physiology White
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Chloroquine-induced maculopathy may progress years after drug cessation and an apparent period of visual stability. Both doctor and patients should be fully aware of the risks of retinal toxicity, including delayed onset and progression. It is therefore crucial that regular monitoring continues in affected patients, long after the initial diagnosis of maculopathy.
ISSN:	1757-790X 1757-790X
DOI:	10.1136/bcr-2017-220598